CALYPTE BIOMEDICAL CORP: 10-Q/A filed 2011-11-30
What CALYPTE BIOMEDICAL CORP reported in its quarterly report amendment filed 2011-11-30 (fiscal Q2 2011): 29 published measures, 74 facts as tagged in accession 0001437749-11-009085.
This is an amendment. Values here are as tagged in the amendment; the original filing has its own page.
This filing
- Form
- 10-Q/A (quarterly report amendment)
- Filed
- 2011-11-30
- Fiscal period
- fiscal Q2 2011
- Accession
- 0001437749-11-009085 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CALYPTE BIOMEDICAL CORP filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 2,201,000 | USD | |
| At 2010-12-31 | 2,331,000 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 6,812,000 | USD | |
| At 2010-12-31 | 7,425,000 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | -4,611,000 | USD | |
| At 2010-12-31 | -5,094,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 175,000 | USD | |
| At 2010-12-31 | 79,000 | USD | |
| At 2010-06-30 | 55,000 | USD | |
| At 2009-12-31 | 176,000 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | -296,000 | USD | 91 |
| 2011-01-01 to 2011-06-30 | -195,000 | USD | 181 |
| 2010-04-01 to 2010-06-30 | -686,000 | USD | 91 |
| 2010-01-01 to 2010-06-30 | -1,233,000 | USD | 181 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-06-30 | -81,000 | USD | 181 |
| 2010-01-01 to 2010-06-30 | -451,000 | USD | 181 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-06-30 | 177,000 | USD | 181 |
| 2010-01-01 to 2010-06-30 | 334,000 | USD | 181 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | -179,606,000 | USD | |
| At 2010-12-31 | -179,411,000 | USD |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | 547,826,000 | shares | 91 |
| 2011-01-01 to 2011-06-30 | 543,849,000 | shares | 181 |
| 2010-04-01 to 2010-06-30 | 477,344,000 | shares | 91 |
| 2010-01-01 to 2010-06-30 | 471,905,000 | shares | 181 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | 2,000 | USD | 91 |
| 2011-01-01 to 2011-06-30 | -178,000 | USD | 181 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 53,000 | USD | |
| At 2010-12-31 | 68,000 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-06-30 | 2,000 | USD | 181 |
| 2010-01-01 to 2010-06-30 | 38,000 | USD | 181 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | -286,000 | USD | 91 |
| 2011-01-01 to 2011-06-30 | -525,000 | USD | 181 |
| 2010-04-01 to 2010-06-30 | -227,000 | USD | 91 |
| 2010-01-01 to 2010-06-30 | -500,000 | USD | 181 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 382,000 | USD | |
| At 2010-12-31 | 403,000 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | 30,000 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 61,000 | USD | 181 |
| 2010-04-01 to 2010-06-30 | 242,000 | USD | 91 |
| 2010-01-01 to 2010-06-30 | 484,000 | USD | 181 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 3,216,000 | USD | |
| At 2010-12-31 | 3,889,000 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 1,749,000 | USD | |
| At 2010-12-31 | 1,843,000 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 39,000 | USD | |
| At 2010-12-31 | 21,000 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | 421,000 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 923,000 | USD | 181 |
| 2010-04-01 to 2010-06-30 | 286,000 | USD | 91 |
| 2010-01-01 to 2010-06-30 | 690,000 | USD | 181 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 135,000 | USD | |
| At 2010-12-31 | 264,000 | USD |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | 205,000 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 454,000 | USD | 181 |
| 2010-04-01 to 2010-06-30 | 210,000 | USD | 91 |
| 2010-01-01 to 2010-06-30 | 486,000 | USD | 181 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-06-30 | 67,000 | USD | 91 |
| 2011-01-01 to 2011-06-30 | 141,000 | USD | 181 |
| 2010-04-01 to 2010-06-30 | 36,000 | USD | 91 |
| 2010-01-01 to 2010-06-30 | 120,000 | USD | 181 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 547,826,416 | shares | |
| At 2010-12-31 | 525,159,750 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 159,747,000 | USD | |
| At 2010-12-31 | 159,749,000 | USD |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | -1,000 | USD | |
| At 2010-12-31 | -1,000 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 360,000 | USD | |
| At 2010-12-31 | 345,000 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-06-30 | 17,000 | USD | |
| At 2010-12-31 | 17,000 | USD |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-06-30 | 109,000 | USD | 181 |
| 2010-01-01 to 2010-06-30 | 215,000 | USD | 181 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-06-30 | 129,000 | USD | 181 |
| 2010-01-01 to 2010-06-30 | -103,000 | USD | 181 |
Inspect the source
- Entity
- CALYPTE BIOMEDICAL CORP / CIK 0000899426
- Captured
- SEC response SHA-256
87a6f8ba9635d2344c32f5be93126dae42d9148dc2fbe4907e89312adcca8e6c
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000899426.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))